Cefpodoxime Proxetil + Clavulanic Acid: Brands, Price & Uses in Bangladesh

Cefpodoxime Proxetil + Clavulanic Acid is a combination antibiotic used to treat bacterial infections caused by organisms that produce beta-lactamase enzymes, which would otherwise make the infection resistant to cefpodoxime alone. The clavulanic acid component blocks these enzymes, restoring the effectiveness of cefpodoxime against a broader range of bacteria.

Established/Guideline-supported uses

• Upper and lower respiratory tract infections, including acute bacterial sinusitis, pharyngitis/tonsillitis, and acute exacerbation of chronic bronchitis, when caused by beta-lactamase-producing pathogens.
• Community-acquired pneumonia due to susceptible, beta-lactamase-producing organisms.
• Acute otitis media in children caused by beta-lactamase-producing strains.
• Uncomplicated urinary tract infections caused by beta-lactamase-producing organisms.
• Skin and soft tissue infections (e.g. cellulitis, abscess, wound infection) caused by beta-lactamase-producing bacteria.
• Ear, nose and throat (ENT) infections such as recurrent or treatment-resistant sinusitis and otitis media.

Cefpodoxime Proxetil + Clavulanic Acid should only be used for infections confirmed or strongly suspected to be caused by susceptible bacteria. It is not effective against viral infections such as the common cold or flu.

The dose of Cefpodoxime Proxetil + Clavulanic Acid depends on the type and severity of infection, age, and renal function. It should always be taken exactly as prescribed by a physician.

Renal impairment: In patients with significantly reduced kidney function (creatinine clearance below approximately 30 mL/min), the dosing interval is generally extended (e.g. to once daily) under a physician's guidance, since cefpodoxime is eliminated mainly by the kidneys.

Hepatic impairment: No specific dose adjustment is generally required for cefpodoxime in hepatic impairment, but caution is advised given the association of the clavulanic acid component with hepatic effects (see Precautions and Warnings).

Administration: Take Cefpodoxime Proxetil + Clavulanic Acid tablets with food to enhance absorption and reduce stomach upset. Shake the reconstituted oral suspension well before each dose and use the provided measuring device. Space doses evenly (e.g. every 12 hours). Take exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice. Completing the full prescribed course is essential even if symptoms improve early, to prevent relapse and antibiotic resistance.

Like all medicines, Cefpodoxime Proxetil + Clavulanic Acid can cause side effects, though not everyone experiences them.

Common

• Diarrhea, loose stools, nausea, vomiting, abdominal pain or discomfort (the clavulanic acid component is associated with a higher rate of gastrointestinal upset than cefpodoxime alone).
• Skin rash.
• Headache.

Less common / Serious

• Hypersensitivity reactions, including urticaria (hives), itching, and, rarely, severe anaphylactic reactions.
• Clostridioides difficile-associated diarrhea (antibiotic-associated colitis), which can range from mild to life-threatening and may occur during or after treatment (class warning for cephalosporins).
• Liver enzyme elevations and, rarely, cholestatic jaundice or hepatic dysfunction, more often reported with clavulanic acid-containing combinations, sometimes with delayed onset after stopping the medicine.
• Vaginal candidiasis (yeast infection).
• Rarely, blood count changes (e.g. eosinophilia) or a positive direct Coombs test without hemolysis.

Seek urgent medical attention for signs of a severe allergic reaction (swelling of the face/throat, difficulty breathing, severe rash), watery or bloody diarrhea that does not improve, or yellowing of the skin/eyes.